Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

1.

Absence of cerebrospinal fluid signs of neuronal injury before and after immediate antiretroviral therapy in acute HIV infection.

Peluso MJ, Valcour V, Ananworanich J, Sithinamsuwan P, Chalermchai T, Fletcher JL, Lerdlum S, Chomchey N, Slike B, Sailasuta N, Gisslén M, Zetterberg H, Spudich S; RV254/SEARCH 010 and SEARCH 011 Study Teams.

J Infect Dis. 2015 May 20. pii: jiv296. [Epub ahead of print]

PMID:
25995196
2.

Comparable antigenicity and immunogenicity of oligomeric forms of a novel, acute HIV-1 subtype C gp145 envelope for use in preclinical and clinical vaccine research.

Wieczorek L, Krebs SJ, Kalyanaraman V, Whitney S, Tovanabutra S, Moscoso CG, Sanders-Buell E, Williams C, Slike B, Molnar S, Dussupt V, Alam SM, Chenine AL, Tong T, Hill EL, Liao HX, Hoelscher M, Maboko L, Zolla-Pazner S, Haynes BF, Pensiero M, McCutchan F, Malek-Salehi S, Cheng RH, Robb ML, VanCott T, Michael NL, Marovich MA, Alving CR, Matyas GR, Rao M, Polonis VR.

J Virol. 2015 May 13. pii: JVI.00412-15. [Epub ahead of print]

PMID:
25972551
3.

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.

Valcour VG, Ananworanich J, Agsalda M, Sailasuta N, Chalermchai T, Schuetz A, Shikuma C, Liang CY, Jirajariyavej S, Sithinamsuwan P, Tipsuk S, Clifford DB, Paul R, Fletcher JL, Marovich MA, Slike BM, DeGruttola V, Shiramizu B; SEARCH 011 Protocol Team.

PLoS One. 2013 Jul 31;8(7):e70164. doi: 10.1371/journal.pone.0070164. Print 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/18c308ec-1cff-4e93-b4bb-6c9fc3a25a15.

4.

Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection.

Boonnak K, Slike BM, Donofrio GC, Marovich MA.

J Immunol. 2013 Jun 1;190(11):5659-65. doi: 10.4049/jimmunol.1203052. Epub 2013 Apr 24.

5.

Prospective surveillance for cardiac adverse events in healthy adults receiving modified vaccinia Ankara vaccines: a systematic review.

Elizaga ML, Vasan S, Marovich MA, Sato AH, Lawrence DN, Chaitman BR, Frey SE, Keefer MC; MVA Cardiac Safety Working Group.

PLoS One. 2013;8(1):e54407. doi: 10.1371/journal.pone.0054407. Epub 2013 Jan 17.

6.

Central nervous system viral invasion and inflammation during acute HIV infection.

Valcour V, Chalermchai T, Sailasuta N, Marovich M, Lerdlum S, Suttichom D, Suwanwela NC, Jagodzinski L, Michael N, Spudich S, van Griensven F, de Souza M, Kim J, Ananworanich J; RV254/SEARCH 010 Study Group.

J Infect Dis. 2012 Jul 15;206(2):275-82. doi: 10.1093/infdis/jis326. Epub 2012 May 2.

7.

Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection.

Ananworanich J, Schuetz A, Vandergeeten C, Sereti I, de Souza M, Rerknimitr R, Dewar R, Marovich M, van Griensven F, Sekaly R, Pinyakorn S, Phanuphak N, Trichavaroj R, Rutvisuttinunt W, Chomchey N, Paris R, Peel S, Valcour V, Maldarelli F, Chomont N, Michael N, Phanuphak P, Kim JH; RV254/SEARCH 010 Study Group.

PLoS One. 2012;7(3):e33948. doi: 10.1371/journal.pone.0033948. Epub 2012 Mar 30.

8.

A double-blind randomized phase I clinical trial targeting ALVAC-HIV vaccine to human dendritic cells.

Eller MA, Slike BM, Cox JH, Lesho E, Wang Z, Currier JR, Darden JM, Polonis VR, Vahey MT, Peel S, Robb ML, Michael NL, Marovich MA.

PLoS One. 2011;6(9):e24254. doi: 10.1371/journal.pone.0024254. Epub 2011 Sep 16.

9.

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate.

Currier JR, Ngauy V, de Souza MS, Ratto-Kim S, Cox JH, Polonis VR, Earl P, Moss B, Peel S, Slike B, Sriplienchan S, Thongcharoen P, Paris RM, Robb ML, Kim J, Michael NL, Marovich MA.

PLoS One. 2010 Nov 15;5(11):e13983. doi: 10.1371/journal.pone.0013983.

10.

Mutational separation of aminoacylation and cytokine activities of human tyrosyl-tRNA synthetase.

Kapoor M, Otero FJ, Slike BM, Ewalt KL, Yang XL.

Chem Biol. 2009 May 29;16(5):531-9. doi: 10.1016/j.chembiol.2009.03.006.

11.

Role of dendritic cells in antibody-dependent enhancement of dengue virus infection.

Boonnak K, Slike BM, Burgess TH, Mason RM, Wu SJ, Sun P, Porter K, Rudiman IF, Yuwono D, Puthavathana P, Marovich MA.

J Virol. 2008 Apr;82(8):3939-51. doi: 10.1128/JVI.02484-07. Epub 2008 Feb 13.

12.

Gain-of-function mutational activation of human tRNA synthetase procytokine.

Yang XL, Kapoor M, Otero FJ, Slike BM, Tsuruta H, Frausto R, Bates A, Ewalt KL, Cheresh DA, Schimmel P.

Chem Biol. 2007 Dec;14(12):1323-33.

13.

Evaluation of aldrithiol-2-inactivated preparations of HIV type 1 subtypes A, B, and D as reagents to monitor T cell responses.

Rutebemberwa A, Bess JW Jr, Brown B, Arroyo M, Eller M, Slike B, Polonis V, McCutchan F, Currier JR, Birx D, Robb M, Marovich M, Lifson JD, Cox JH.

AIDS Res Hum Retroviruses. 2007 Apr;23(4):532-42.

PMID:
17506610
14.

Direct comparison of antigen production and induction of apoptosis by canarypox virus- and modified vaccinia virus ankara-human immunodeficiency virus vaccine vectors.

Zhang X, Cassis-Ghavami F, Eller M, Currier J, Slike BM, Chen X, Tartaglia J, Marovich M, Spearman P.

J Virol. 2007 Jul;81(13):7022-33. Epub 2007 Apr 4.

15.

Pseudovirion particle production by live poxvirus human immunodeficiency virus vaccine vector enhances humoral and cellular immune responses.

Chen X, Rock MT, Hammonds J, Tartaglia J, Shintani A, Currier J, Slike B, Crowe JE Jr, Marovich M, Spearman P.

J Virol. 2005 May;79(9):5537-47.

16.

Variant of human enzyme sequesters reactive intermediate.

Ewalt KL, Yang XL, Otero FJ, Liu J, Slike B, Schimmel P.

Biochemistry. 2005 Mar 22;44(11):4216-21.

PMID:
15766249
17.

Induction of angiogenesis by a fragment of human tyrosyl-tRNA synthetase.

Wakasugi K, Slike BM, Hood J, Ewalt KL, Cheresh DA, Schimmel P.

J Biol Chem. 2002 Jun 7;277(23):20124-6. Epub 2002 Apr 15.

18.

A human aminoacyl-tRNA synthetase as a regulator of angiogenesis.

Wakasugi K, Slike BM, Hood J, Otani A, Ewalt KL, Friedlander M, Cheresh DA, Schimmel P.

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):173-7. Epub 2002 Jan 2.

19.

A fragment of human TrpRS as a potent antagonist of ocular angiogenesis.

Otani A, Slike BM, Dorrell MI, Hood J, Kinder K, Ewalt KL, Cheresh D, Schimmel P, Friedlander M.

Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):178-83. Epub 2002 Jan 2.

20.

Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG.

Lowell GH, Kaminski RW, VanCott TC, Slike B, Kersey K, Zawoznik E, Loomis-Price L, Smith G, Redfield RR, Amselem S, Birx DL.

J Infect Dis. 1997 Feb;175(2):292-301.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk